These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 8621796)

  • 1. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.
    Desai-Mehta A; Lu L; Ramsey-Goldman R; Datta SK
    J Clin Invest; 1996 May; 97(9):2063-73. PubMed ID: 8621796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
    Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N
    Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus.
    Harigai M; Hara M; Fukasawa C; Nakazawa S; Kawaguchi Y; Kamatani N; Kashiwazaki S
    Lupus; 1999; 8(3):227-33. PubMed ID: 10342716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.
    Koshy M; Berger D; Crow MK
    J Clin Invest; 1996 Aug; 98(3):826-37. PubMed ID: 8698875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus.
    Blossom S; Chu EB; Weigle WO; Gilbert KM
    J Immunol; 1997 Nov; 159(9):4580-6. PubMed ID: 9379059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of circulating follicular helper T cells in lupus patients is associated with autoantibody production in a CD40L-dependent manner.
    Xu H; Liu J; Cui X; Zuo Y; Zhang Z; Li Y; Tao R; Li Y; Pang J
    Cell Immunol; 2015 May; 295(1):46-51. PubMed ID: 25748125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
    Devi BS; Van Noordin S; Krausz T; Davies KA
    J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells.
    Yi Y; McNerney M; Datta SK
    J Immunol; 2000 Dec; 165(11):6627-34. PubMed ID: 11086108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
    Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
    Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response.
    Jaiswal AI; Croft M
    J Immunol; 1997 Sep; 159(5):2282-91. PubMed ID: 9278317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
    Bijl M; Horst G; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct roles of ICOS and CD40L in human T-B cell adhesion and antibody production.
    Liu Z; Liu S; Zhang Y; Zeng W; Wang S; Ji P; Pan M; Zhu C; Wang Y
    Cell Immunol; 2021 Oct; 368():104420. PubMed ID: 34418679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
    Early GS; Zhao W; Burns CM
    J Immunol; 1996 Oct; 157(7):3159-64. PubMed ID: 8816428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S
    Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E4BP4 overexpression: a protective mechanism in CD4+ T cells from SLE patients.
    Zhao M; Liu Q; Liang G; Wang L; Luo S; Tang Q; Zhao H; Su Y; Yung S; Chan TM; Lu Q
    J Autoimmun; 2013 Mar; 41():152-60. PubMed ID: 23340290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ T lymphocytes with constitutive CD40 ligand in preautoimmune (NZB x NZW)F1 lupus-prone mice: phenotype and possible role in autoreactivity.
    Lettesjö H; Burd GP; Mageed RA
    J Immunol; 2000 Oct; 165(7):4095-104. PubMed ID: 11034421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism.
    Nakamura M; Tanaka Y; Satoh T; Kawai M; Hirakata M; Kaburaki J; Kawakami Y; Ikeda Y; Kuwana M
    Rheumatology (Oxford); 2006 Feb; 45(2):150-6. PubMed ID: 16188945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease.
    Battaglia E; Biancone L; Resegotti A; Emanuelli G; Fronda GR; Camussi G
    Am J Gastroenterol; 1999 Nov; 94(11):3279-84. PubMed ID: 10566730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus.
    Katsiari CG; Liossis SN; Souliotis VL; Dimopoulos AM; Manoussakis MN; Sfikakis PP
    Clin Immunol; 2002 Apr; 103(1):54-62. PubMed ID: 11987985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients.
    Marken J; Muralidharan S; Giltiay NV
    Arthritis Res Ther; 2021 Jan; 23(1):5. PubMed ID: 33407802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.